Using IHC, the exosomal markers (CD63 and CD9) expression increased in patients with rectal adenocarcinoma after treatment with NCCR and thus suggest a possible role of these exosomes in adaptive response to NCCR. The gene discussed is CD9; the disease is rectum adenocarcinoma.